Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alice Dallatomasina

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Theranostics|March 14, 2015
Theranostic impact of NG2/CSPG4 proteoglycan in cancerPier Andrea Nicolosi, Alice Dallatomasina, Roberto Perris
Core Evidence|September 14, 2016
Everolimus in the management of metastatic renal cell carcinoma: an evidence-based review of its place in therapySebastiano Buti, Alessandro Leonetti, Alice Dallatomasina, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 15, 2018
Structural deciphering of the NG2/CSPG4 proteoglycan multifunctionalityElisa Tamburini, Alice Dallatomasina, Jade Quartararo, et al.
Plos One|January 4, 2014
Diversified expression of NG2/CSPG4 isoforms in glioblastoma and human foetal brain identifies pericyte subsetsFrancesco Girolamo, Alice Dallatomasina, Marco Rizzi, et al.
Cancer Research|February 24, 2019
Spatiotemporal Regulation of Tumor Angiogenesis by Circulating Chromogranin A Cleavage and Neuropilin-1 EngagementAlice Dallatomasina, Anna Maria Gasparri, Barbara Colombo, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 12, 2019
Physiological levels of chromogranin A prevent doxorubicin-induced cardiotoxicity without impairing its anticancer activityCarmine Rocca, Francesco Scavello, Barbara Colombo, et al.
Plos One|May 4, 2018
Vasostatin-1: A novel circulating biomarker for ileal and pancreatic neuroendocrine neoplasmsAndrea Corsello, Luigi Di Filippo, Sara Massironi, et al.
Oncotarget|September 30, 2016
Regulation of tumor growth by circulating full-length chromogranin AFlavio Curnis, Alice Dallatomasina, Mimma Bianco, et al.
Frontiers in Oncology|January 11, 2021
Circulating Chromogranin A Is Cleaved Into Vasoregulatory Fragments in Patients With Pancreatic Ductal AdenocarcinomaMichele Reni, Valentina Andreasi, Anna Maria Gasparri, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Theranostics|March 14, 2015
Theranostic impact of NG2/CSPG4 proteoglycan in cancerPier Andrea Nicolosi, Alice Dallatomasina, Roberto Perris
Core Evidence|September 14, 2016
Everolimus in the management of metastatic renal cell carcinoma: an evidence-based review of its place in therapySebastiano Buti, Alessandro Leonetti, Alice Dallatomasina, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 15, 2018
Structural deciphering of the NG2/CSPG4 proteoglycan multifunctionalityElisa Tamburini, Alice Dallatomasina, Jade Quartararo, et al.
Plos One|January 4, 2014
Diversified expression of NG2/CSPG4 isoforms in glioblastoma and human foetal brain identifies pericyte subsetsFrancesco Girolamo, Alice Dallatomasina, Marco Rizzi, et al.
Cancer Research|February 24, 2019
Spatiotemporal Regulation of Tumor Angiogenesis by Circulating Chromogranin A Cleavage and Neuropilin-1 EngagementAlice Dallatomasina, Anna Maria Gasparri, Barbara Colombo, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 12, 2019
Physiological levels of chromogranin A prevent doxorubicin-induced cardiotoxicity without impairing its anticancer activityCarmine Rocca, Francesco Scavello, Barbara Colombo, et al.
Plos One|May 4, 2018
Vasostatin-1: A novel circulating biomarker for ileal and pancreatic neuroendocrine neoplasmsAndrea Corsello, Luigi Di Filippo, Sara Massironi, et al.
Oncotarget|September 30, 2016
Regulation of tumor growth by circulating full-length chromogranin AFlavio Curnis, Alice Dallatomasina, Mimma Bianco, et al.
Frontiers in Oncology|January 11, 2021
Circulating Chromogranin A Is Cleaved Into Vasoregulatory Fragments in Patients With Pancreatic Ductal AdenocarcinomaMichele Reni, Valentina Andreasi, Anna Maria Gasparri, et al.
Pageof 1